XML 22 R40.htm IDEA: XBRL DOCUMENT v3.20.1
Segmented information (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Summary of Revenues Relating to Geographic Segments The revenues relating to geographic segments based on customer location, in United States dollars, for the years ended December 31, 2019 and 2018 are as follows

 

 

 

2019

 

 

2018

 

Revenue:

 

 

 

 

 

 

 

 

Canada and other

 

$

225,807

 

 

$

271,803

 

United States

 

 

120,159,467

 

 

 

112,477,577

 

Total

 

$

120,385,274

 

 

$

112,749,380

 

 

Summary of Revenue from Contract with Customer

The Company’s revenues are disaggregated below into categories which differ in terms of the economic factors which impact the amount, timing and uncertainty of revenue and cash flows.

 

 

 

2019

 

 

2018

 

Revenue:

 

 

 

 

 

 

 

 

Commercial Insurers

 

$

90,332,380

 

 

$

86,992,218

 

Federal Insurers

 

 

19,404,851

 

 

 

14,246,626

 

Physicians

 

 

10,078,843

 

 

 

10,959,215

 

Other

 

 

569,200

 

 

 

551,321

 

Total

 

$

120,385,274

 

 

$

112,749,380

 

 

 

Summary of Property and Equipment, Intangibles and Other Assets Located in Geographic Regions

The Company’s property and equipment, intangibles, other assets and total assets are located in the following geographic regions as at December 31, 2019 and 2018:

 

 

 

2019

 

 

2018

 

Property and equipment:

 

 

 

 

 

 

 

 

Canada

 

$

210,386

 

 

$

276,621

 

United States

 

$

41,547

 

 

 

26,670

 

Total

 

$

251,933

 

 

$

303,291

 

Intangible assets:

 

 

 

 

 

 

 

 

Canada

 

$

30,478

 

 

$

32,735

 

United States

 

$

163,077,715

 

 

 

179,351,528

 

Total

 

$

163,108,193

 

 

$

179,384,263

 

Total assets:

 

 

 

 

 

 

 

 

Canada

 

$

3,231,845

 

 

$

9,293,796

 

United States

 

$

199,863,424

 

 

 

209,694,200

 

Total

 

$

203,095,269

 

 

$

218,987,996

 

 

Summary of Operating Segments

The financial measures reviewed by the Company’s Chief Operating Decision Maker are presented below for the years ended December 31, 2019 and 2018.  The Company does not allocate expenses related to corporate activities.  These expenses are presented within “Other” to allow for reconciliation to reported measures.

 

 

 

2019

 

 

 

Anesthesia

services

 

 

Product sales

 

 

Other

 

 

Total

 

Revenue

 

$

110,306,431

 

 

$

10,078,843

 

 

$

—

 

 

$

120,385,274

 

Operating costs

 

 

94,506,039

 

 

 

4,647,719

 

 

 

6,549,321

 

 

 

105,703,079

 

Operating income (loss)

 

$

15,800,392

 

 

$

5,431,124

 

 

$

(6,549,321

)

 

$

14,682,195

 

 

 

 

2018

 

 

 

Anesthesia

services

 

 

Product sales

 

 

Other

 

 

Total

 

Revenue

 

$

101,790,165

 

 

$

10,959,215

 

 

$

—

 

 

$

112,749,380

 

Operating costs

 

 

81,079,150

 

 

 

5,022,737

 

 

 

6,352,363

 

 

 

92,454,250

 

Operating income (loss)

 

$

20,711,015

 

 

$

5,936,478

 

 

$

(6,352,363

)

 

$

20,295,130

 

 

Additionally, the company incurs the following in each of its operating segments:

 

 

 

2019

 

 

 

Anesthesia

services

 

 

Product sales

 

 

Other

 

 

Total

 

Finance expense

 

$

2,994,654

 

 

$

—

 

 

$

3,614,964

 

 

$

6,609,618

 

Depreciation and amortization expense

 

$

34,908,764

 

 

$

25,534

 

 

$

74,772

 

 

$

35,009,070

 

 

 

 

2018

 

 

 

Anesthesia

services

 

 

Product sales

 

 

Other

 

 

Total

 

Finance expense

 

$

1,138,200

 

 

$

—

 

 

$

3,429,127

 

 

$

4,567,327

 

Depreciation and amortization expense

 

$

31,394,245

 

 

$

68,509

 

 

$

23,301

 

 

$

31,486,055